pulmonary-fibrosis-natural-treatment

The Lung Institute Offers Natural Treatment Options for Pulmonary Fibrosis

Natural treatment options for pulmonary fibrosis can include making lifestyle changes such as getting more exercise, maintaining a healthy diet and quitting smoking. At the Lung Institute, we are proud to offer an additional natural approach to treating pulmonary fibrosis – cellular therapy. As the world’s only cellular therapy center that focuses exclusively on the treatment of lung conditions, we offer a unique opportunity to work with a dedicated medical team that truly specializes in pulmonary care through cellular therapy.

We offer cellular therapy, with the goal of reducing lung inflammation, improving lung function and potentially slowing the progression of pulmonary fibrosis. These forms include Blood-Derived Therapy (in which the cells are derived from the patient’s own blood). During the minimally invasive procedure, our caring medical team will:

  • Draw the blood from the patient’s body
  • Separate the cells from the other cells in our onsite lab
  • Intravenously reintroduce the separated cells into the patient’s body to help stimulate the body’s natural healing processes

Because the cellular therapy we perform is autologous, or coming from the patient’s own body, there is very little risk of rejection.  The treatment is performed on an outpatient basis over the course of two days, and most patients are able to return to their regular activities immediately following the procedure. While no treatment can reverse lung damage, regenerate tissue or cure lung disease, cellular therapy can potentially slow the progression of the condition and improve the patient’s overall quality of life.

To learn more about how cellular therapy can be used as a natural treatment option for pulmonary fibrosis, call the Lung Institute team today at (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.